Newest figures come from the 10-Q for Q1 FY2026, filed May 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SSSS SEC filings page.
This page shows Suro Capital Corp (SSSS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The business is governed by asset-return volatility, alongside a mostly equity-funded balance sheet.
FY2025's cash conversion was incomplete: net income of$48.8M produced operating cash flow of$34.3M , or70.3% , so reported earnings did not fully arrive as cash in the same period. That differed from FY2024, when a net loss of-$38.1M coincided with positive operating cash flow of$2.4M , suggesting period-specific items affect earnings and cash differently.
The earnings cycle is unusually wide: return on assets moved from
The balance-sheet posture became less debt-dependent, with debt-to-equity declining from 0.5x in FY2024 to 0.3x in FY2025. The company also distributed
Financial Health Signals
Suro Capital Corp does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Suro Capital Corp passes 3 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
For every $1 of reported earnings, Suro Capital Corp generates $0.70 in operating cash flow ($34.3M OCF vs $48.8M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Key Financial Metrics
Earnings & Revenue
Suro Capital Corp reported $155.6M in net income in Q1 2026. This represents an increase of 19392.6% from the same quarter a year earlier. Against the prior quarter it is up 873.2%.
Suro Capital Corp earned $5.18 per diluted share (EPS) in Q1 2026. This represents an increase of 17366.7% from the same quarter a year earlier. Against the prior quarter it is up 747.5%.
Not reported for Q1 2026.
Not reported for Q1 2026.
Cash & Balance Sheet
Suro Capital Corp held $43.3M in cash as of Q1 2026; long-term debt is not reported for that period.
Not reported for Q1 2026.
Not reported for Q1 2026.
Margins & Returns
Suro Capital Corp's ROE was 43.0% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is up 43.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 52.8 percentage points.
Not reported for Q1 2026.
Not reported for Q1 2026.
Not reported for Q1 2026.
Capital Allocation
None of these metrics is reported for Q1 2026.
SSSS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-Q | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Interest Expense | $1.2M-3.4% | N/A | $1.3M+10.7% | $1.3M+5.0% | $1.3M+3.8% | N/A | $1.2M-5.1% | $1.2M0.0% |
| Income Tax | $58K+1958.6% | N/A | N/A | -$219K-514.3% | $3K+33.1% | N/A | N/A | $53K-41.9% |
| Net Income | $155.6M+19392.6% | -$20.1M-45308.8% | $7.4M+236.0% | $62.3M+685.2% | -$807K+96.3% | $45K+100.5% | -$5.5M-121.6% | -$10.7M+31.8% |
| EPS (Basic) | $6.13+20533.3% | -$0.80 | $0.30+230.4% | $2.63+684.4% | -$0.03+96.6% | N/A | -$0.23-123.2% | -$0.45+25.0% |
| EPS (Diluted) | $5.18+17366.7% | -$0.80 | $0.28+221.7% | $2.23+595.6% | -$0.03+96.6% | N/A | -$0.23-123.2% | -$0.45+25.0% |
| Diluted Shares (Avg) | 30M+28.0% | 25M+7.6% | 29M+24.0% | 28M+20.6% | 24M-7.2% | 23M-7.2% | 23M-7.8% | 23M-9.8% |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA.
SSSS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-Q | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $433.3M+87.0% | $276.0M+19.2% | $308.3M+31.9% | $295.1M+23.8% | $231.7M-9.8% | $231.6M-16.6% | $233.8M-19.1% | $238.3M-9.4% |
| Cash & Equivalents | $43.3M+167.7% | $49.0M+144.7% | $54.5M+66.6% | $49.9M-8.3% | $16.2M-68.2% | $20.0M-28.9% | $32.7M-55.5% | $54.4M+121.6% |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | $125K | N/A |
| Total Liabilities | $71.7M-4.2% | $70.7M-4.5% | $76.5M+0.2% | $75.6M-0.4% | $74.9M-0.4% | $74.0M-0.3% | $76.3M-0.9% | $76.0M-0.4% |
| Total Equity | $361.6M+130.6% | $205.3M+30.3% | $231.8M+47.2% | $219.4M+35.2% | $156.8M-13.7% | $157.6M-22.5% | $157.4M-25.7% | $162.3M-13.1% |
Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities, Long-Term Debt, Retained Earnings.
SSSS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-Q | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$5.8M-54.8% | $4.4M+135.4% | -$101K+99.5% | $33.7M+160.2% | -$3.7M-116.4% | -$12.4M+72.5% | -$20.9M-142.1% | $13.0M+228.7% |
| Stock-Based Compensation | $599K+1445.2% | N/A | N/A | N/A | $39K-91.0% | N/A | N/A | N/A |
| Financing Cash Flow | -$417+99.7% | -$9.9M-3800.3% | $4.8M+739.4% | -$26K+99.7% | -$136K-26.2% | -$254K-609.6% | -$750K-10.5% | -$9.4M+30.4% |
| Dividends Paid | $500-94.4% | $6.2M+17099.5% | $5.8M | $0 | $9K-91.8% | $36K0.0% | $0 | $0 |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | $0 | $0-100.0% | N/A |
Not reported in any period shown, so not listed: Depreciation & Amortization, Capital Expenditures, Free Cash Flow, Investing Cash Flow.
SSSS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-Q | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Return on Equity | 43.0%+43.6pp | -9.8%-9.8pp | 3.2%+6.7pp | 28.4%+35.0pp | -0.5%+11.6pp | 0.0%+4.5pp | -3.5%-15.3pp | -6.6%+1.8pp |
| Return on Assets | 35.9%+36.3pp | -7.3%-7.3pp | 2.4%+4.7pp | 21.1%+25.6pp | -0.4%+8.2pp | 0.0%+3.3pp | -2.3%-11.1pp | -4.5%+1.5pp |
| Debt-to-Equity | 0.20-0.3x | 0.34-0.1x | 0.33-0.2x | 0.34-0.1x | 0.48+0.1x | 0.47+0.1x | 0.48+0.1x | 0.47+0.1x |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Current Ratio, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Suro Capital Corp SSSS | FY2025 | N/A | $48.8M | N/A | $326.9M | — |
| Ellington Credit Closed End Fund EARN | FY2024 | N/A | $6.6M | N/A | $164.6M | — |
| Whitehorse WHF | FY2025 | N/A | $14.3M | N/A | $152.3M | — |
Where Suro Capital Corp Ranks
Frequently Asked Questions
Is Suro Capital Corp profitable?
Yes, Suro Capital Corp (SSSS) reported a net income of $48.8M in fiscal year 2025.
What is Suro Capital Corp's return on equity (ROE)?
Suro Capital Corp (SSSS) has a return on equity of 23.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Suro Capital Corp's operating cash flow?
Suro Capital Corp (SSSS) generated $34.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Suro Capital Corp's total assets?
Suro Capital Corp (SSSS) had $276.0M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Suro Capital Corp's debt-to-equity ratio?
Suro Capital Corp (SSSS) had a debt-to-equity ratio of 0.34 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Suro Capital Corp's return on assets (ROA)?
Suro Capital Corp (SSSS) had a return on assets of 17.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Suro Capital Corp's Piotroski F-Score?
Suro Capital Corp (SSSS) has a Piotroski F-Score of 3 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Suro Capital Corp's earnings high quality?
Suro Capital Corp (SSSS) has an earnings quality ratio of 0.70x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.